Ledger.Open graph →
SEC Form D · Amendment · filed April 19, 2024

Skylark Bio, Inc

Offering
$40.9M
Sold
$40.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Steve A. Gillis · Cambridge, MADirectorGiampiero A. De Luca · Cambridge, MADirectorJodi A. Cook · Cambridge, MAExec · DirectorWill A. Mclean · Cambridge, MAExecDaniel Portillo · San Francisco, CADirectorWill A. Mclean · Cambridge, MAExecPhineas Barnes · San Francisco, CADirectorJodi A. Cook · Cambridge, MAExec · DirectorKip Mcclanahan · Austin, TXDirectorIgnace O. Van Waesberghe · New York, NYDirectorJared Birchall · Fremont, CAExec · DirectorBryan Baum · Miami Beach, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗